| Product NDC: | 0527-1311 |
| Proprietary Name: | Terbutaline Sulfate |
| Non Proprietary Name: | Terbutaline Sulfate |
| Active Ingredient(s): | 5 mg/1 & nbsp; Terbutaline Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0527-1311 |
| Labeler Name: | Lannett Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077152 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050325 |
| Package NDC: | 0527-1311-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| NDC Code | 0527-1311-01 |
| Proprietary Name | Terbutaline Sulfate |
| Package Description | 100 TABLET in 1 BOTTLE (0527-1311-01) |
| Product NDC | 0527-1311 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terbutaline Sulfate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20050325 |
| Marketing Category Name | ANDA |
| Labeler Name | Lannett Company, Inc. |
| Substance Name | TERBUTALINE SULFATE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |